Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1991 May;35(5):1004–1007. doi: 10.1128/aac.35.5.1004

Effect of staggered dose of calcium on the bioavailability of ciprofloxacin.

B M Lomaestro 1, G R Bailie 1
PMCID: PMC245147  PMID: 1854156

Abstract

The effect on ciprofloxacin's bioavailability (F) of calcium carbonate given 2 h before ciprofloxacin administration in 12 male volunteers was studied. The relative F with calcium was 0.98, maximum concentration of drug in serum increased significantly from 1.98 to 2.42 mg/liter (P = 0.039), and time to maximum concentration of drug in serum decreased from 1.82 to 1.26 h (P = 0.038). Thus, a single calcium carbonate dose, administered 2 h before ciprofloxacin, does not alter the F of this quinolone.

Full text

PDF
1004

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bianchi W., Maggiolo F., Imbasciati A., Ohnmeiss H. K. Antacids and ciprofloxacin pharmacokinetics. Antimicrob Agents Chemother. 1988 Jun;32(6):949–949. doi: 10.1128/aac.32.6.949-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Crump B., Wise R., Dent J. Pharmacokinetics and tissue penetration of ciprofloxacin. Antimicrob Agents Chemother. 1983 Nov;24(5):784–786. doi: 10.1128/aac.24.5.784. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Fleming L. W., Moreland T. A., Stewart W. K., Scott A. C. Ciprofloxacin and antacids. Lancet. 1986 Aug 2;2(8501):294–294. doi: 10.1016/s0140-6736(86)92120-3. [DOI] [PubMed] [Google Scholar]
  4. Höffken G., Borner K., Glatzel P. D., Koeppe P., Lode H. Reduced enteral absorption of ciprofloxacin in the presence of antacids. Eur J Clin Microbiol. 1985 Jun;4(3):345–345. doi: 10.1007/BF02013667. [DOI] [PubMed] [Google Scholar]
  5. Ivanovich P., Fellows H., Rich C. The absorption of calcium carbonate. Ann Intern Med. 1967 May;66(5):917–923. doi: 10.7326/0003-4819-66-5-917. [DOI] [PubMed] [Google Scholar]
  6. Joos B., Ledergerber B., Flepp M., Bettex J. D., Lüthy R., Siegenthaler W. Comparison of high-pressure liquid chromatography and bioassay for determination of ciprofloxacin in serum and urine. Antimicrob Agents Chemother. 1985 Mar;27(3):353–356. doi: 10.1128/aac.27.3.353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kobrin S. M., Goldstein S. J., Shangraw R. F., Raja R. M. Variable efficacy of calcium carbonate tablets. Am J Kidney Dis. 1989 Dec;14(6):461–465. doi: 10.1016/s0272-6386(89)80145-3. [DOI] [PubMed] [Google Scholar]
  8. Lomaestro B. M., Lesar T. S. Concurrent administration of ciprofloxacin and potentially interacting drugs. Am J Hosp Pharm. 1989 Sep;46(9):1770–1770. [PubMed] [Google Scholar]
  9. Nix D. E., Watson W. A., Handy L., Frost R. W., Rescott D. L., Goldstein H. R. The effect of sucralfate pretreatment on the pharmacokinetics of ciprofloxacin. Pharmacotherapy. 1989;9(6):377–380. doi: 10.1002/j.1875-9114.1989.tb04152.x. [DOI] [PubMed] [Google Scholar]
  10. Parpia S. H., Nix D. E., Hejmanowski L. G., Goldstein H. R., Wilton J. H., Schentag J. J. Sucralfate reduces the gastrointestinal absorption of norfloxacin. Antimicrob Agents Chemother. 1989 Jan;33(1):99–102. doi: 10.1128/aac.33.1.99. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Plaisance K. I., Drusano G. L., Forrest A., Bustamante C. I., Standiford H. C. Effect of dose size on bioavailability of ciprofloxacin. Antimicrob Agents Chemother. 1987 Jun;31(6):956–958. doi: 10.1128/aac.31.6.956. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Polk R. E., Healy D. P., Sahai J., Drwal L., Racht E. Effect of ferrous sulfate and multivitamins with zinc on absorption of ciprofloxacin in normal volunteers. Antimicrob Agents Chemother. 1989 Nov;33(11):1841–1844. doi: 10.1128/aac.33.11.1841. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Rubinstein E., Segev S. Drug interactions of ciprofloxacin with other non-antibiotic agents. Am J Med. 1987 Apr 27;82(4A):119–123. [PubMed] [Google Scholar]
  14. Terp D. K., Rybak M. J. Ciprofloxacin. Drug Intell Clin Pharm. 1987 Jul-Aug;21(7-8):568–574. doi: 10.1177/1060028087021007-801. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES